Abstract:Objective To investigate the effects of daurisoline (DAS) on growth and proliferation of glioma U251 and U87 cells and its underlying mechanisms.Methods U251 and U87 cells were treated with different concentrations of daurisoline (2.5, 5.0, and 10.0 μmol/L, DAS groups), 10.0 μmol/L of temozolomide (TMZ group), or left untreated (control group). The CCK-8 assay was used to detect the influence of DAS on cell viability, colony formation assay and EdU assay were used to evaluate the impact of DAS on cell proliferation, and flow cytometry was used to analyze the effect of DAS on cell apoptosis. The formation of autophagosomes was observed under the transmission electron microscopy. Western blotting was performed to detect the expressions of proteins associated with apoptosis, autophagy and Akt/mTOR signaling pathway in glioma cells.Results The CCK-8 assay showed that cell viability of glioma cells treated with DAS was decreased in a concentration-dependent manner compared with that in the control group (P < 0.05). In addition, the cell viability in the DAS group was lower than that in the TMZ group (P < 0.05). The IC50 of glioma U251 and U87 cells was 5.11 μmol/L and 6.35 μmol/L, respectively. The Edu assay and colony formation assay demonstrated that DAS suppressed the proliferation of glioma cells, and that the cell proliferation was successively inhibited with the increase in the drug concentration (P < 0.05). Flow cytometry exhibited that DAS induced apoptosis of glioma cells, and apoptosis aggravated with the increase in the drug concentration (P < 0.05). Western blotting revealed that DAS increased the relative protein expressions of Bax, LC3Ⅱ/Ⅰ, p62, p-AKT, and p-mTOR (P < 0.05) but decreased the relative expression of the anti-apoptotic Bcl-2 protein in glioma cells (P < 0.05). Transmission electron microscopy displayed that DAS promoted the formation of autophagosomes in glioma cells (P < 0.05).Conclusions DAS inhibits the viability and proliferation and promotes apoptosis of glioma cells, which may be associated with the suppression of autophagy by activating the AKT/mTOR signaling pathway.